Literature DB >> 11559567

p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.

D Zhang1, D Cao, R Russell, G Pizzorno.   

Abstract

Uridine phosphorylase (UPase) is a key enzyme in the pyrimidine salvage pathway. It reversibly catalyzes the catabolism of uridine to uracil; controls the homeostatic regulation of uridine concentration in plasma and tissues; and plays a role in the intracellular activation of 5-fluorouracil. We cloned the murine UPase gene promoter, a 1703-bp fragment, and determined the transcription initiation sites located at +1 and +92 bp of the cDNA sequence. Through transient expression analysis of the 5'-flanking region of UPase gene, we have evaluated the promoter activity for a series of fragments with 5'- to 3'-deletion in murine breast cancer EMT-6 cells and immortalized murine fibroblast NIH 3T3 cells. Cotransfection of the UPase promoter constructs (from -1619 to -445) containing p53 binding motif with the wild-type p53 construct resulted in a significant reduction of luciferase activity; however, this effect disappeared with the additional deletion of the -445 to -274 sequence to suggest the existence in this promoter region of a putative p53 recognition element. Similar cotransfection in murine embryo fibroblasts p53-/- confirmed the inhibitory role of p53 on the UPase promoter activity. The specificity of the interaction is demonstrated by nuclear protein-specific binding to the putative p53 recognition sequence using gel mobility shift assay and DNase I footprinting analysis. These data indicate the UPase gene is a novel target of p53, and its expression is down-regulated by p53 at the promoter level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559567

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.

Authors:  Deliang Cao; Amy Ziemba; James McCabe; Ruilan Yan; Laxiang Wan; Bradford Kim; Michael Gach; Stuart Flynn; Giuseppe Pizzorno
Journal:  Mol Cancer Ther       Date:  2011-09-27       Impact factor: 6.261

2.  Transcriptional regulation of the novel Toll-like receptor Tlr13.

Authors:  Zhongcheng Shi; Zhenyu Cai; Shu Wen; Caoyi Chen; Christi Gendron; Amir Sanchez; Kevin Patterson; Songbin Fu; Jianhua Yang; Derek Wildman; Richard H Finnell; Dekai Zhang
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

3.  Nucleotide biosynthesis links glutathione metabolism to ferroptosis sensitivity.

Authors:  Amy Tarangelo; Jason Rodencal; Joon Tae Kim; Leslie Magtanong; Jonathan Z Long; Scott J Dixon
Journal:  Life Sci Alliance       Date:  2022-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.